EUVIMEDEUVIMED entdecken
Crossref

Risk Stratification of Acute Pulmonary Embolism: Outcomes in Patients With Intermediate sPESI Scores and Negative Cardiac Biomarkers

Michael Dore iD, Ryan Duffy iD, Omar Melikechi iD

Academic Emergency Medicine · 2026-10 · 33 (10)

DOI: 10.1111/acem.70425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academic Emergency Medicine, online erschienen am 07.10.2026. Verfasst von Michael Dore und 2 weiteren Autor:innen. Beteiligte Einrichtung: Durham Veterans Affairs Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Pulmonary Embolism. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current pulmonary embolism (PE) guidelines support outpatient management for selected low‐risk patients, typically identified using the simplified Pulmonary Embolism Severity Index (sPESI). The prognostic value of individual sPESI scores in the direct oral anticoagulant (DOAC) era, particularly when combined with cardiac biomarker assessment, remains uncertain. Research Question To evaluate 7‐day and 30‐day all‐cause mortality among patients with acute PE, sPESI scores of 2 or 3, and negative cardiac biomarkers treated with a DOAC. Study Design and Methods Retrospective cohort study of US adults diagnosed with acute PE in a VA emergency department and prescribed a DOAC within 24 h of diagnosis at any U.S. Veterans Affairs (VA) Health System from 2015 to 2024. Main Outcome Measures Seven‐day and 30‐day all‐cause mortality.

Results

Of 6427 eligible patients, 1365 had an sPESI score of 2 and 455 had an sPESI score of 3 with negative cardiac biomarkers. In the sPESI 2 cohort, 7‐day and 30‐day mortality were 0.44% and 1.39%, respectively. In the sPESI 3 cohort, rates were 0.22% and 2.20%. Approximately 71% of sPESI 2 patients and 75% of sPESI 3 patients were hospitalized. Hospitalization was not associated with lower 7‐day or 30‐day mortality in either cohort.

Interpretation

Patients with acute PE, sPESI scores of 2 or 3, and negative cardiac biomarkers had low short‐term mortality in this large, contemporary DOAC‐treated cohort. These findings support prospective studies evaluating outpatient management in carefully selected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismHumansRetrospective StudiesBiomarkersFemaleRisk AssessmentMaleAgedSeverity of Illness IndexMiddle AgedUnited StatesAnticoagulantsPrognosisAcute DiseaseEmergency Service, HospitalNatriuretic Peptide, Brain

Stichwörter der Autor:innen

cardiac biomarkerspulmonary embolismsPESI

Substanzen

BiomarkersAnticoagulantsNatriuretic Peptide, Brain

Autor:innen und Institutionen

  • Durham Veterans Affairs Medical Center, Durham, North Carolina, USA.
  • Duke University School of Medicine, Durham, North Carolina, USA.
  • Duke University, Department of Statistical Science and Mathematics, Durham, North Carolina, USA.

ORCID-Profile: Michael Dore, Ryan Duffy, Omar Melikechi

Zitieren

APA

Dore, M., Duffy, R., & Melikechi, O. (2026). Risk Stratification of Acute Pulmonary Embolism: Outcomes in Patients With Intermediate sPESI Scores and Negative Cardiac Biomarkers. Academic Emergency Medicine, 33(10). https://doi.org/10.1111/acem.70425

Vancouver

Dore M, Duffy R, Melikechi O. Risk Stratification of Acute Pulmonary Embolism: Outcomes in Patients With Intermediate sPESI Scores and Negative Cardiac Biomarkers. Academic Emergency Medicine. 2026;33(10). doi:10.1111/acem.70425

BibTeX
@article{Dore2026,
  author = {Dore, Michael and Duffy, Ryan and Melikechi, Omar},
  title = {Risk Stratification of Acute Pulmonary Embolism: Outcomes in Patients With Intermediate sPESI Scores and Negative Cardiac Biomarkers},
  journal = {Academic Emergency Medicine},
  year = {2026},
  volume = {33},
  number = {10},
  doi = {10.1111/acem.70425}
}
Kostenlos starten →